The utility of next generation sequencing-based minimal residual disease monitoring in a post-myeloproliferative neoplasm acute myeloid leukemia patient: a case report
[MORPHOLOGY OF THE RESIDUAL TESTICULAR PARENCHYMA IN TESTICLES WITH SEMINAL NEOPLASMS AS AN INDEX OF EVENTUAL CONDITIONS FAVORING TUMOR DEVIATION].
[Expert consensus on minimal residual disease detection of acute leukemia and plasma cell neoplasms by multi-parameter flow cytometry].
